Envista Holdings Corp. (NVST)
NYSE · Common · CUSIP 29415F104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NVST and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29415F104
IPO
9/18/2019 · $22.00/share
Business: Envista Holdings Corp. is one of the largest global dental products companies with significant market positions in some of the most attractive segments of the dental products industry, including implants, orthodontics and digital imaging technologies. The Company develops, manufactures and markets one of the most comprehensive portfolios of dental consumables, equipment and services to dental professionals covering an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile.
Notes: Jul 22, 2019 -- Danaher Corporation will spin its Nobel Biocare Systems, KaVo Kerr, and Ormco companies off into a separate company named Envista Holdings Corporation via an initial public offering in the second half of 2019. Amir Aghdaei, who is currently a Danaher group executive responsible for the company’s dental segment, will be Envista’s president and chief executive officer.

Company Contact

CEO
Amir Aghdaei
CFO
Howard H. Yu
Headquarters
200 S. Kraemer Blvd., Building E Brea, CA 92821
Phone
714-817-7000
Investor Relations
John Bedford · 714-516-7576 · ir@envistaco.com
SEC EDGAR Filings
View filings »